# Early High-Dose Vitamin D and Residual β-Cell Function in Pediatric Type 1 Diabetes

> **NCT05270343** · PHASE3 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 198 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Cholecalciferol (Vit D3) 400Unit Cap

## Key facts

- **NCT ID:** NCT05270343
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2024-12-30
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2022-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05270343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05270343, "Early High-Dose Vitamin D and Residual β-Cell Function in Pediatric Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05270343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*